Organicell Regenerative Medicine

Miami, United States

Organicell Regenerative Medicine is an exosome therapeutics company with a focus on developing new biologic medicine.

$4.0M raised

Jul 2022

Post-IPO Equity

Biotechnology Health Care Life Science Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Organicell Regenerative Medicine

How much funding has Organicell Regenerative Medicine raised?

Organicell Regenerative Medicine has raised $4.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2022.

Where is Organicell Regenerative Medicine headquartered?

Organicell Regenerative Medicine is headquartered in Miami, United States.

What does Organicell Regenerative Medicine do?

Organicell Regenerative Medicine is an exosome therapeutics company with a focus on developing new biologic medicine.

What stage is Organicell Regenerative Medicine at?

Organicell Regenerative Medicine is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 20, 2022.

MLA

"Organicell Regenerative Medicine — Funding & Investors." VCBacked, July 20, 2022, https://www.vcbacked.co/company/organicell-regenerative-medicine. Accessed July 2, 2026.

APA

VCBacked. (2022). Organicell Regenerative Medicine — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/organicell-regenerative-medicine

Wikipedia (cite web)

{{cite web |title=Organicell Regenerative Medicine — Funding & Investors |url=https://www.vcbacked.co/company/organicell-regenerative-medicine |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 20, 2022.